The Tøpholm and Westermann families have alongside private equity firm EQT injected a triple-digit million-euro sum into hearing aid manufacturer WS Audiology, the company confirms to media Inside Business.

”WSA’s owners, T&W Medical and EQT, have chosen to strengthen liquidity in the company in the current macroeconomic environment, and have therefore come with a EUR 100m capital injection,” WSA writes in a mail to the media.

This comes after a year during which the hearing aid maker suffered great losses. Its deficit came to around EUR 270m in the financial year of 2021/2022, which was bigger than the EUR 81.9m loss the year before.

Over the same periods, WSA’s revenues increased from EUR 2.1bn in 2020/2021 to EUR 2.4bn the following year.

WS Audiology is a merger company comprising Widex and Sivantos, which conjoined in the Spring of 2019. The year after, the ownership circle of the two families and EQT injected EUR 50m into the company, which also took out a loan.

In January 2021, it was revealed that the Tøpholm and Westermann families had assumed the majority owner role of WSA from EQT. The two families own their share through holding company T&W Medical.

EQT has its stake via funds EQT VII and EQT VIII.